Merck KGaA Forecasts Earnings, Sales Growth

Merck KGaA ‘back on the growth path’
Germany’s Merck KGaA (MRK: DE) returned to profitable growth in 2024 and delivered on its guidance for the year.
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
Merck KGaA expects earnings and sales growth this year after reporting a rise in annual earnings on temporarily reduced research and development expenses in its healthcare segment and strict cost discipline.
Merck KGaA reports YE24 earnings growth amid SpringWorks acquisition talks
While the company is in discussions to acquire SpringWorks, it did not elaborate on these talks in its earnings call.
Merck KGaA sees forex-adjusted earnings growth of up to 8% this year
Merck KGaA on Thursday forecast currency-adjusted operating earnings growth of up to 8%, helped by demand for semiconductor chemicals and for lab equipment in biotech drug production. The German group said in a statement that 2025 earnings before interest,
Merck KGaA Sees Slow Profit Growth This Year Amid Recovery
Merck KGaA forecast slow profit growth for this year as its life science business continues to recover and the boom in AI lifts demand at its semiconductor division.
Merck KGaA (MKGAF) Q4 2024 Earnings Call Transcript
Q4 2024 Results Conference Call March 6, 2025 8:00 AM ETCompany ParticipantsFlorian Schraeder - Head of Investor
Merck sees slight earnings, sales growth in 2025
German science and technology company Merck on Thursday forecast its net sales to be in the range of €21.5 billion ($23.2 billion) and €22.9 billion in 2025. It also projects its adjusted earnings before interest,
Merck KGaA to replace two executives with company veterans
Germany's Merck KGaA said on Tuesday its lab equipment division and its pharmaceuticals division would be under new leadership from June but it added that its strategy remains unchanged. Jean-Charles ...
Pharmabiz12d
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...
Fierce Pharma3d
In patent clash over injectable Keytruda, Merck and Halozyme dig in for a fight
Both Merck & Co. and Halozyme are holding their ground in a freshly unveiled patent dispute surrounding the New Jersey pharma ...
Morningstar19d
Germany's Merck Appoints Chiefs of Life Science, Healthcare Business Sectors
The German pharmaceutical-and ... Wirth as new chief executive of life science. Wirth succeeds Matthias Heinzel, who decided to not renew his contract, Merck said. Danny Bar-Zohar was ...
Delaware approves $30.2 million taxpayer-funded grant for Merck to build in state
The state of Delaware has offered Merck a $30.2 million grant to encourage the company to choose the Wilmington-area location. If Merck accepts the grant, the company would be required to create 375 ...
Fierce Pharma10d
Merck nabs $30M grant commitment from Delaware as state looks to entice Big Pharma investment
As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a ...
Rapid Micro Biosystems Announces Global Distribution and Collaboration Agreement with the Life Science business of Merck KGaA, Darmstadt, Germany
Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...
Medical Dialogues10d
Merck unveils Formulation & Technology Center in Navi Mumbai
Merck Life Science has unveiled its Formulation & Technology Centre in Turbhe, Navi Mumbai.As a key part of Merck’s global ...